-
2
-
-
33646198145
-
Tau therapeutic strategies for the treatment of Alzheimer's disease
-
Churcher I. Tau therapeutic strategies for the treatment of Alzheimer's disease. Curr. Top. Med. Chem. 6 (2006) 579-595
-
(2006)
Curr. Top. Med. Chem.
, vol.6
, pp. 579-595
-
-
Churcher, I.1
-
3
-
-
25844458239
-
Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies
-
Ferrer I., et al. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies. Curr. Alzheimer Res. 2 (2005) 3-18
-
(2005)
Curr. Alzheimer Res.
, vol.2
, pp. 3-18
-
-
Ferrer, I.1
-
4
-
-
34548191034
-
Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis
-
Hanger D.P., et al. Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J. Biol. Chem. 282 (2007) 23645-23654
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 23645-23654
-
-
Hanger, D.P.1
-
5
-
-
0024641959
-
Developmentally regulated expression of specific tau sequences
-
Kosik K.S., et al. Developmentally regulated expression of specific tau sequences. Neuron 2 (1989) 1389-1397
-
(1989)
Neuron
, vol.2
, pp. 1389-1397
-
-
Kosik, K.S.1
-
6
-
-
0024745894
-
Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease
-
Goedert M., et al. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3 (1989) 519-526
-
(1989)
Neuron
, vol.3
, pp. 519-526
-
-
Goedert, M.1
-
7
-
-
34347387536
-
Tau-4R suppresses proliferation and promotes neuronal differentiation in the hippocampus of tau knockin/knockout mice
-
Sennvik K., et al. Tau-4R suppresses proliferation and promotes neuronal differentiation in the hippocampus of tau knockin/knockout mice. FASEB J. 21 (2007) 2149-2161
-
(2007)
FASEB J.
, vol.21
, pp. 2149-2161
-
-
Sennvik, K.1
-
8
-
-
0033850407
-
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
-
Buee L., et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev 33 (2000) 95-130
-
(2000)
Brain Res. Brain Res. Rev
, vol.33
, pp. 95-130
-
-
Buee, L.1
-
9
-
-
0037414833
-
Glycogen synthase kinase 3β phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding
-
Cho J.H., and Johnson G.V. Glycogen synthase kinase 3β phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding. J. Biol. Chem. 278 (2003) 187-193
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 187-193
-
-
Cho, J.H.1
Johnson, G.V.2
-
10
-
-
33947140574
-
Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism?
-
Balastik M., et al. Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism?. Biochim. Biophys. Acta 1772 (2007) 422-429
-
(2007)
Biochim. Biophys. Acta
, vol.1772
, pp. 422-429
-
-
Balastik, M.1
-
11
-
-
0033600242
-
The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein
-
Lu P.J., et al. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399 (1999) 784-788
-
(1999)
Nature
, vol.399
, pp. 784-788
-
-
Lu, P.J.1
-
12
-
-
33750589818
-
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
-
Buerger K., et al. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease. Brain 129 (2006) 3035-3041
-
(2006)
Brain
, vol.129
, pp. 3035-3041
-
-
Buerger, K.1
-
13
-
-
0037197836
-
Tau is essential to β-amyloid-induced neurotoxicity
-
Rapoport M., et al. Tau is essential to β-amyloid-induced neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 6364-6369
-
(2002)
Proc. Natl. Acad. Sci. U. S. A.
, vol.99
, pp. 6364-6369
-
-
Rapoport, M.1
-
14
-
-
22344438508
-
Tau suppression in a neurodegenerative mouse model improves memory function
-
SantaCruz K., et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309 (2005) 476-481
-
(2005)
Science
, vol.309
, pp. 476-481
-
-
SantaCruz, K.1
-
15
-
-
34248181511
-
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
-
Roberson E.D., et al. Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model. Science 316 (2007) 750-754
-
(2007)
Science
, vol.316
, pp. 750-754
-
-
Roberson, E.D.1
-
16
-
-
53149150976
-
Glucocorticoids trigger Alzheimer disease-like pathobiochemistry in rat neuronal cells expressing human tau
-
Sotiropoulos I., et al. Glucocorticoids trigger Alzheimer disease-like pathobiochemistry in rat neuronal cells expressing human tau. J. Neurochem. 107 (2008) 385-397
-
(2008)
J. Neurochem.
, vol.107
, pp. 385-397
-
-
Sotiropoulos, I.1
-
17
-
-
20044367108
-
Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms
-
Andorfer C., et al. Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J. Neurosci. 25 (2005) 5446-5454
-
(2005)
J. Neurosci.
, vol.25
, pp. 5446-5454
-
-
Andorfer, C.1
-
18
-
-
34447503455
-
Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases
-
Mazanetz M.P., and Fischer P.M. Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases. Nat. Rev. Drug Discov. 6 (2007) 464-479
-
(2007)
Nat. Rev. Drug Discov.
, vol.6
, pp. 464-479
-
-
Mazanetz, M.P.1
Fischer, P.M.2
-
19
-
-
21044449225
-
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo
-
Noble W., et al. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 6990-6995
-
(2005)
Proc. Natl. Acad. Sci. U. S. A.
, vol.102
, pp. 6990-6995
-
-
Noble, W.1
-
20
-
-
34250818767
-
Lithium reduces tau phosphorylation but not Aβ or working memory deficits in a transgenic model with both plaques and tangles
-
Caccamo A., et al. Lithium reduces tau phosphorylation but not Aβ or working memory deficits in a transgenic model with both plaques and tangles. Am. J. Pathol. 170 (2007) 1669-1675
-
(2007)
Am. J. Pathol.
, vol.170
, pp. 1669-1675
-
-
Caccamo, A.1
-
21
-
-
58349114277
-
Inhibition of glycogen synthase kinase-3β downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A
-
Martin L., et al. Inhibition of glycogen synthase kinase-3β downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A. Brain Res. 1252 (2009) 66-75
-
(2009)
Brain Res.
, vol.1252
, pp. 66-75
-
-
Martin, L.1
-
22
-
-
33745449875
-
An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice
-
Le Corre S., et al. An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 20 (2006) 9673-9678
-
(2006)
Proc. Natl. Acad. Sci. U. S. A.
, vol.20
, pp. 9673-9678
-
-
Le Corre, S.1
-
23
-
-
40449098952
-
Amyloid activates GSK-3β to aggravate neuronal tauopathy in bigenic mice
-
Terwel D., et al. Amyloid activates GSK-3β to aggravate neuronal tauopathy in bigenic mice. Am. J. Pathol. 172 (2008) 786-798
-
(2008)
Am. J. Pathol.
, vol.172
, pp. 786-798
-
-
Terwel, D.1
-
24
-
-
0038689162
-
Cdk5 is a key factor in tau aggregation and tangle formation in vivo
-
Noble W., et al. Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38 (2003) 555-565
-
(2003)
Neuron
, vol.38
, pp. 555-565
-
-
Noble, W.1
-
25
-
-
22244475384
-
Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase
-
Derkinderen P., et al. Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase. J. Neurosci. 25 (2005) 6584-6593
-
(2005)
J. Neurosci.
, vol.25
, pp. 6584-6593
-
-
Derkinderen, P.1
-
26
-
-
11544279355
-
Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins
-
Lambert M.P., et al. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6448-6453
-
(1998)
Proc. Natl. Acad. Sci. U. S. A.
, vol.95
, pp. 6448-6453
-
-
Lambert, M.P.1
-
27
-
-
43249114144
-
Membrane-bound β-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism
-
Williamson R., et al. Membrane-bound β-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism. FASEB J. 22 (2008) 1552-1559
-
(2008)
FASEB J.
, vol.22
, pp. 1552-1559
-
-
Williamson, R.1
-
28
-
-
23744482703
-
Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates
-
Vega I.E., et al. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates. Brain Res. Mol. Brain Res. 138 (2005) 135-144
-
(2005)
Brain Res. Mol. Brain Res.
, vol.138
, pp. 135-144
-
-
Vega, I.E.1
-
29
-
-
49649119504
-
Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cγ1, Grb2, and Src family kinases
-
Reynolds C.H., et al. Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cγ1, Grb2, and Src family kinases. J. Biol. Chem. 283 (2008) 18177-18186
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 18177-18186
-
-
Reynolds, C.H.1
-
30
-
-
46749128127
-
Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic
-
Medina M., and Castro A. Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic. Curr. Opin. Drug Discov. Devel. 11 (2008) 533-543
-
(2008)
Curr. Opin. Drug Discov. Devel.
, vol.11
, pp. 533-543
-
-
Medina, M.1
Castro, A.2
-
31
-
-
38449088277
-
Antibody-based approaches in Alzheimer's research: safety, pharmacokinetics, metabolism, and analytical tools
-
Lichtlen P., and Mohajeri M.H. Antibody-based approaches in Alzheimer's research: safety, pharmacokinetics, metabolism, and analytical tools. J. Neurochem. 104 (2008) 859-874
-
(2008)
J. Neurochem.
, vol.104
, pp. 859-874
-
-
Lichtlen, P.1
Mohajeri, M.H.2
-
32
-
-
49249118742
-
Neurotoxic effect of oligomeric and fibrillar species of amyloid-β peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death
-
Resende R., et al. Neurotoxic effect of oligomeric and fibrillar species of amyloid-β peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death. Neuroscience 155 (2008) 725-737
-
(2008)
Neuroscience
, vol.155
, pp. 725-737
-
-
Resende, R.1
-
33
-
-
37049011456
-
Inhibition of tau aggregation in cell models of tauopathy
-
Khlistunova I., et al. Inhibition of tau aggregation in cell models of tauopathy. Curr. Alzheimer Res. 4 (2007) 544-546
-
(2007)
Curr. Alzheimer Res.
, vol.4
, pp. 544-546
-
-
Khlistunova, I.1
-
34
-
-
34548691220
-
N-phenylamine derivatives as aggregation inhibitors in cell models of tauopathy
-
Pickhardt M., et al. N-phenylamine derivatives as aggregation inhibitors in cell models of tauopathy. Curr. Alzheimer Res. 4 (2007) 397-402
-
(2007)
Curr. Alzheimer Res.
, vol.4
, pp. 397-402
-
-
Pickhardt, M.1
-
35
-
-
10944220830
-
Modeling tauopathy: a range of complementary approaches
-
Hall G.F., and Yao J. Modeling tauopathy: a range of complementary approaches. Biochim. Biophys. Acta 1739 (2005) 224-239
-
(2005)
Biochim. Biophys. Acta
, vol.1739
, pp. 224-239
-
-
Hall, G.F.1
Yao, J.2
-
36
-
-
34147125835
-
Accumulation of pathological tau species and memory loss in a conditional model of tauopathy
-
Berger Z., et al. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J. Neurosci. 27 (2007) 3650-3662
-
(2007)
J. Neurosci.
, vol.27
, pp. 3650-3662
-
-
Berger, Z.1
-
37
-
-
34548146119
-
Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements
-
Asuni A.A., et al. Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements. J. Neurosci. 27 (2007) 9115-9129
-
(2007)
J. Neurosci.
, vol.27
, pp. 9115-9129
-
-
Asuni, A.A.1
-
38
-
-
5444273804
-
MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons
-
Mandelkow E.M., et al. MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons. J. Cell Biol. 167 (2004) 99-110
-
(2004)
J. Cell Biol.
, vol.167
, pp. 99-110
-
-
Mandelkow, E.M.1
-
39
-
-
4444262625
-
Cdk5 deregulation in the pathogenesis of Alzheimer's disease
-
Cruz J.C., and Tsai L.H. Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends Mol. Med. 10 (2004) 452-458
-
(2004)
Trends Mol. Med.
, vol.10
, pp. 452-458
-
-
Cruz, J.C.1
Tsai, L.H.2
-
40
-
-
0035223461
-
Sites of phosphorylation in tau and factors affecting their regulation
-
Anderton B.H., et al. Sites of phosphorylation in tau and factors affecting their regulation. Biochem. Soc. Symp. 67 (2001) 73-80
-
(2001)
Biochem. Soc. Symp.
, Issue.67
, pp. 73-80
-
-
Anderton, B.H.1
-
41
-
-
14044270858
-
Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38δ at Thr50 promotes microtubule assembly
-
Feijoo C., et al. Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38δ at Thr50 promotes microtubule assembly. J. Cell Sci. 118 (2005) 397-408
-
(2005)
J. Cell Sci.
, vol.118
, pp. 397-408
-
-
Feijoo, C.1
-
42
-
-
1942469505
-
Casein kinase 1δ phosphorylates tau and disrupts its binding to microtubules
-
Li G., et al. Casein kinase 1δ phosphorylates tau and disrupts its binding to microtubules. J. Biol. Chem. 279 (2004) 15938-15945
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 15938-15945
-
-
Li, G.1
-
43
-
-
0032951956
-
Hierarchical phosphorylation of recombinant tau by the paired-helical filament-associated protein kinase is dependent on cyclic AMP-dependent protein kinase
-
Jicha G.A., et al. Hierarchical phosphorylation of recombinant tau by the paired-helical filament-associated protein kinase is dependent on cyclic AMP-dependent protein kinase. J. Neurochem. 72 (1999) 214-224
-
(1999)
J. Neurochem.
, vol.72
, pp. 214-224
-
-
Jicha, G.A.1
-
44
-
-
0030943263
-
Stress-activated protein kinase/c-Jun N-terminal kinase phosphorylates τ protein
-
Reynolds C.H., et al. Stress-activated protein kinase/c-Jun N-terminal kinase phosphorylates τ protein. J. Neurochem. 68 (1997) 1736-1744
-
(1997)
J. Neurochem.
, vol.68
, pp. 1736-1744
-
-
Reynolds, C.H.1
-
45
-
-
0030918416
-
Reactivating kinase/p38 phosphorylates tau protein in vitro
-
Reynolds C.H., et al. Reactivating kinase/p38 phosphorylates tau protein in vitro. J. Neurochem. 69 (1997) 191-198
-
(1997)
J. Neurochem.
, vol.69
, pp. 191-198
-
-
Reynolds, C.H.1
-
46
-
-
4644360412
-
MARKing tau for tangles and toxicity
-
Drewes G. MARKing tau for tangles and toxicity. Trends Biochem. Sci. 29 (2004) 548-555
-
(2004)
Trends Biochem. Sci.
, vol.29
, pp. 548-555
-
-
Drewes, G.1
-
47
-
-
0035340295
-
The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bε at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase
-
Woods Y.L., et al. The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bε at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem. J. 355 (2001) 609-615
-
(2001)
Biochem. J.
, vol.355
, pp. 609-615
-
-
Woods, Y.L.1
-
48
-
-
33644849088
-
Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3β
-
Li T., et al. Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3β. Biochemistry 45 (2006) 3134-3145
-
(2006)
Biochemistry
, vol.45
, pp. 3134-3145
-
-
Li, T.1
-
49
-
-
0028899714
-
Proline-directed and non-proline-directed phosphorylation of PHF-tau
-
Morishima-Kawashima M., et al. Proline-directed and non-proline-directed phosphorylation of PHF-tau. J. Biol. Chem. 270 (1995) 823-829
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 823-829
-
-
Morishima-Kawashima, M.1
-
50
-
-
0027984739
-
Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein
-
Goedert M., et al. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem. J. 301 (1994) 871-877
-
(1994)
Biochem. J.
, vol.301
, pp. 871-877
-
-
Goedert, M.1
-
51
-
-
0030936599
-
Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau
-
Jicha G.A., et al. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J. Neurosci. Res. 48 (1997) 128-132
-
(1997)
J. Neurosci. Res.
, vol.48
, pp. 128-132
-
-
Jicha, G.A.1
-
52
-
-
0030750558
-
Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites
-
Hoffmann R., et al. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites. Biochemistry 36 (1997) 8114-8124
-
(1997)
Biochemistry
, vol.36
, pp. 8114-8124
-
-
Hoffmann, R.1
-
53
-
-
44649100169
-
Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats
-
Wray S., et al. Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats. J. Neurochem. 105 (2008) 2343-2352
-
(2008)
J. Neurochem.
, vol.105
, pp. 2343-2352
-
-
Wray, S.1
-
54
-
-
0027945346
-
Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau
-
Matsuo E.S., et al. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 13 (1994) 989-1002
-
(1994)
Neuron
, vol.13
, pp. 989-1002
-
-
Matsuo, E.S.1
-
55
-
-
0029010035
-
Hyperphosphorylation of tau in PHF
-
Morishima-Kawashima M., et al. Hyperphosphorylation of tau in PHF. Neurobiol. Aging 16 (1995) 365-371
-
(1995)
Neurobiol. Aging
, vol.16
, pp. 365-371
-
-
Morishima-Kawashima, M.1
-
56
-
-
0027372016
-
The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments
-
Kenessey A., and Yen S.H. The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments. Brain Res. 629 (1993) 40-46
-
(1993)
Brain Res.
, vol.629
, pp. 40-46
-
-
Kenessey, A.1
Yen, S.H.2
-
57
-
-
0027429479
-
Developmental changes in tau phosphorylation: fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease
-
Brion J.-P., et al. Developmental changes in tau phosphorylation: fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease. J. Neurochem. 61 (1993) 2071-2080
-
(1993)
J. Neurochem.
, vol.61
, pp. 2071-2080
-
-
Brion, J.-P.1
-
58
-
-
0036938326
-
Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms
-
Tolnay M., et al. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms. Acta Neuropathol. 104 (2002) 425-434
-
(2002)
Acta Neuropathol.
, vol.104
, pp. 425-434
-
-
Tolnay, M.1
-
59
-
-
4344562126
-
Mechanism of phosphorylation-dependent binding of APC to β-catenin and its role in β-catenin degradation
-
Ha N.C., et al. Mechanism of phosphorylation-dependent binding of APC to β-catenin and its role in β-catenin degradation. Mol. Cell 15 (2004) 511-521
-
(2004)
Mol. Cell
, vol.15
, pp. 511-521
-
-
Ha, N.C.1
-
60
-
-
0033613199
-
Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation
-
Sharma P., et al. Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 11156-11160
-
(1999)
Proc. Natl. Acad. Sci. U. S. A.
, vol.96
, pp. 11156-11160
-
-
Sharma, P.1
-
61
-
-
0033710860
-
Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth
-
Zukerberg L.R., et al. Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron 26 (2000) 633-646
-
(2000)
Neuron
, vol.26
, pp. 633-646
-
-
Zukerberg, L.R.1
-
62
-
-
51849134550
-
Neurofilament tail phosphorylation: identity of the RT-97 phosphoepitope and regulation in neurons by cross-talk among proline-directed kinases
-
Veeranna E., et al. Neurofilament tail phosphorylation: identity of the RT-97 phosphoepitope and regulation in neurons by cross-talk among proline-directed kinases. J. Neurochem. 107 (2008) 35-49
-
(2008)
J. Neurochem.
, vol.107
, pp. 35-49
-
-
Veeranna, E.1
-
63
-
-
43249111278
-
Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I
-
Gontarewicz A., et al. Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I. Blood 111 (2008) 4355-4364
-
(2008)
Blood
, vol.111
, pp. 4355-4364
-
-
Gontarewicz, A.1
-
64
-
-
40449087334
-
Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3β mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing
-
Wen Y., et al. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3β mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. J. Neurosci. 28 (2008) 2624-2632
-
(2008)
J. Neurosci.
, vol.28
, pp. 2624-2632
-
-
Wen, Y.1
-
65
-
-
0344011447
-
Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice
-
Hallows J.L., et al. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice. J. Neurosci. 23 (2003) 10633-10644
-
(2003)
J. Neurosci.
, vol.23
, pp. 10633-10644
-
-
Hallows, J.L.1
-
66
-
-
40249114794
-
Transcriptional regulation of β-secretase by p25/cdk5 leads to enhanced amyloidogenic processing
-
Wen Y., et al. Transcriptional regulation of β-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron 57 (2008) 680-690
-
(2008)
Neuron
, vol.57
, pp. 680-690
-
-
Wen, Y.1
-
67
-
-
0038187674
-
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
-
Phiel C.J., et al. GSK-3α regulates production of Alzheimer's disease amyloid-β peptides. Nature 423 (2003) 435-439
-
(2003)
Nature
, vol.423
, pp. 435-439
-
-
Phiel, C.J.1
-
68
-
-
34247187312
-
Regulation of Alzheimer's disease amyloid- formation by casein kinase I
-
Flajolet M., et al. Regulation of Alzheimer's disease amyloid- formation by casein kinase I. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 4159-4164
-
(2007)
Proc. Natl. Acad. Sci. U. S. A.
, vol.104
, pp. 4159-4164
-
-
Flajolet, M.1
-
69
-
-
0031741247
-
New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry
-
Hanger D.P., et al. New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry. J. Neurochem. 71 (1998) 2465-2476
-
(1998)
J. Neurochem.
, vol.71
, pp. 2465-2476
-
-
Hanger, D.P.1
-
70
-
-
0034067992
-
Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta
-
Reynolds C.H., et al. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J. Neurochem. 74 (2000) 1587-1595
-
(2000)
J. Neurochem.
, vol.74
, pp. 1587-1595
-
-
Reynolds, C.H.1
-
71
-
-
0027421625
-
Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments
-
Paudel H.K., et al. Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. J. Biol. Chem. 268 (1993) 23512-23518
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 23512-23518
-
-
Paudel, H.K.1
-
72
-
-
0031727983
-
Ser-262 in human recombinant tau protein is a markedly more favorable site for phosphorylation by CaMKII than PKA or PhK
-
Sironi J.J., et al. Ser-262 in human recombinant tau protein is a markedly more favorable site for phosphorylation by CaMKII than PKA or PhK. FEBS Lett. 436 (1998) 471-475
-
(1998)
FEBS Lett.
, vol.436
, pp. 471-475
-
-
Sironi, J.J.1
-
73
-
-
0033596946
-
Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments
-
Schneider A., et al. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry 38 (1999) 3549-3558
-
(1999)
Biochemistry
, vol.38
, pp. 3549-3558
-
-
Schneider, A.1
|